New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β₂ agonists in combination or combined into a single molecule

By Norman Peter  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1569-1580

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic M1 receptor agonists and M2 receptor antagonists as therapeutic targets in Alzheimer’s disease

By Sheardown Malcolm J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Long-acting &bgr;₂ agonists: Pfizer’s development candidate?

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1753-1757

Informa Healthcare

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic receptor agonists and antagonists

By Zlotos D.P.   Bender W.   Holzgrabe U.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. : 1029-1053

Informa Healthcare

Access to resources Recommend Favorite